Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value, $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
1.95M
-
Shares change
-
+1.63M
-
Total reported value, excl. options
-
$3.77M
-
Value change
-
+$3.07M
-
Number of buys
-
8
-
Number of sells
-
-3
-
Price
-
$1.94
Significant Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q4 2021
13 filings reported holding NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share as of Q4 2021.
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.95M shares
of 50M outstanding shares and own 3.89% of the company stock.
Largest 10 shareholders include Stonepine Capital Management, LLC (498K shares), AIGH Capital Management LLC (475K shares), Bleichroeder LP (375K shares), VANGUARD GROUP INC (217K shares), Worth Venture Partners, LLC (109K shares), Eidelman Virant Capital (75K shares), DRIVE WEALTH MANAGEMENT, LLC (66.7K shares), Intersect Capital LLC (50K shares), Aristides Capital LLC (36.8K shares), and NORTHERN TRUST CORP (15.4K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.